Disorders of Gut Microbiota and Plasma Metabolic Profiles May Be Associated with Lymph Node Tuberculosis
Microorganisms · 23.06.2025 · 13 (7) · 1456
DOI: 10.3390/microorganisms13071456 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microorganisms, online erschienen am 23.06.2025. Verfasst von Yun Long und 11 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen Third People's Hospital, National Clinical Research Centre for Infectious Disease, The Second Affiliated Hospital of Southern University of …. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Shenzhen Third People's Hospital Research Fund, National Key R&D Program of china, High Level Special Funds (Cell Homeostasis and Major Diseases).
Abstract (Originalsprache)
The association of gut microbiota with lymph node tuberculosis (LNTB) remains unexplored. This study employed metagenomic sequencing and plasma metabolomics analyses to investigate the role of gut microbiota in LNTB patients. Significant alterations in gut microbial diversity were observed in LNTB patients, characterized by a notable reduction in bacterial taxa involved in short-chain fatty acid (SCFA) synthesis, including Ruminococcus, Faecalibacterium, Roseburia, and Blautia, compared to healthy individuals. KEGG pathway analysis further revealed that gut dysbiosis could negatively impact SCFA biosynthesis and metabolism. Plasma metabolomics demonstrated disruptions in metabolites associated with SCFA synthesis and inflammation pathways in the LNTB group. Integrated analysis indicated significant correlations between specific gut microbiota (Blautia, Butyricicoccus, Coprococcus, Ruminococcus, Bacteroides, Clostridium) and plasma metabolites, including α-benzylbutyric acid, acetic acid, and succinic acid. Our findings demonstrate that gut microbiota dysbiosis and related metabolic dysfunction significantly reduce SCFA production in LNTB patients, potentially identifying novel therapeutic targets for LNTB management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shenzhen Third People's Hospital, National Clinical Research Centre for Infectious Disease, The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen 518112, China.
- Department of Pharmacology, Joint Laboratory of Guangdong-Hong Kong Universities for Vascular Homeostasis and Diseases, SUSTech Homeostatic Medicine Institute, School of Medicine, Southern University of Science and Tech…
ORCID-Profile: Zhe Liu
Förderung
- the Shenzhen Third People's Hospital Research Fund
- National Key R&D Program of china
- High Level Special Funds (Cell Homeostasis and Major Diseases)
- Shenzhen Third People’s Hospital Research Fund
- National Key R&D Program of China
Zitieren
APA
Long, Y., Huang, J., Zheng, S., Bai, S., Liu, Z., Li, X., Gao, W., Ke, X., Tang, Y., Yang, L., Wang, H., & Li, G. (2025). Disorders of Gut Microbiota and Plasma Metabolic Profiles May Be Associated with Lymph Node Tuberculosis. Microorganisms, 13(7), 1456. https://doi.org/10.3390/microorganisms13071456
Vancouver
Long Y, Huang J, Zheng S, Bai S, Liu Z, Li X, et al. Disorders of Gut Microbiota and Plasma Metabolic Profiles May Be Associated with Lymph Node Tuberculosis. Microorganisms. 2025;13(7):1456. doi:10.3390/microorganisms13071456
BibTeX
@article{Long2025,
author = {Long, Yun and Huang, Jiamin and Zheng, Shasha and Bai, Shimeng and Liu, Zhe and Li, Xue and Gao, Wenying and Ke, Xue and Tang, Yunyan and Yang, Liang and Wang, Haijiang and Li, Guobao},
title = {Disorders of Gut Microbiota and Plasma Metabolic Profiles May Be Associated with Lymph Node Tuberculosis},
journal = {Microorganisms},
year = {2025},
volume = {13},
number = {7},
pages = {1456},
doi = {10.3390/microorganisms13071456}
}
EUVIMED